Evidence map›Paper›PMID 20520583›Full record

ArticlePediatric research2010

Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice.

Kultar Singh, Ling Xiu Zhang, Kreso Bendelja, Ryan Heath, Shaun Murphy, Surendra Sharma, James F Padbury, Yow-Pin Lim

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The Endothelial Glycocalyx and Neonatal Sepsis.International journal of molecular sciences · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kultar SinghDepartment of Pediatrics, Women & Infants' Hospital, Brown Medical School, Providence, RI 02905, USA.
Ling Xiu Zhang
Kreso Bendelja
Ryan Heath
Shaun Murphy
Surendra Sharma
James F Padbury
Yow-Pin Lim
Rhode Island Hospital · USWomen & Infants Hospital of Rhode Island · USProvidence College · US

Funding

UTERINE NK CELL HOMING FROM THE PERIPHERAL CIRCULATIONP20RR018728 · NCRR · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI BLISS, JOSEPH MARK · 2003 to 2011
$16.7M
Inter-alpha Inhibitors in Neonatal SepsisR21HD047600 · NICHD · RHODE ISLAND HOSPITAL · PI LIM, YOW-PIN · 2004 to 2005
$398k
NCRR NIH HHS P20 RR018728NICHD NIH HHS R21 HD047600
6 · The paper itself

Abstract

Inter-alpha inhibitor proteins (IaIp) are serine proteases inhibitors that modulate endogenous protease activity and have been shown to improve survival in adult models of sepsis. We evaluated the effect of IaIp on survival and systemic responses to sepsis in neonatal mice. Sepsis was induced in 2-d-old mice with lipopolysaccharide (LPS), Escherichia coli, and group B Streptococci. Sepsis was associated with 75% mortality. IaIp, given by i.p. administration at doses between 15 and 45 mg/kg from 1 to 6 h after the onset of sepsis, improved survival to approximately 90% (p = 0.0159) in both LPS-induced sepsis and with live bacterial infections. The greatest effect was on reversal of hemorrhagic pneumonitis. The effects were dose and time dependent. Systemic cytokine profile and tissue histology were examined. Survival was compared in IL-10 knock out animals. Systemic cytokine levels including TNF-[alpha] and IL-10 were increased after induction of sepsis and modulated significantly after IaIp administration. Because the effect of IaIp was still demonstrable in IL-10 deficient mice, we conclude the beneficial effects of IaIp is because of suppression of proinflammatory cytokines such as TNF-[alpha] rather than augmentation of IL-10. IaIp may offer significant benefits as a therapeutic

Indexed as

Escherichia coliStreptococcus agalactiaeAlpha-GlobulinsAnimalsCytokinesDose-Response Relationship, DrugHumansInfant, NewbornInfant, Newborn, DiseasesLipopolysaccharidesMiceSepsisSerine Proteinase InhibitorsSurvival AnalysisTime FactorsAlpha-GlobulinsCytokinesinter-alpha-inhibitorLipopolysaccharidesSerine Proteinase Inhibitors

Identifiers

PMID20520583
PMCPMC2928396
OpenAlexW1986711186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.